Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Matthew Alan
Matthew Alan Foister, Cincinnati, OH US
| Patent application number | Description | Published |
|---|---|---|
| 20090084767 | SYSTEM AND METHOD FOR CONTROLLING LASER SHOCK PEENING - A laser shock peening system including a workpiece is provided. The laser shock peening system includes a workholding fixture configured to hold the workpiece. The laser shock peening system also includes a laser source configured to emit multiple laser beam pulses on the workpiece. The laser shock peening system further includes an absorptive layer disposed on the workpiece, the absorptive layer configured to absorb the laser beam pulses from the laser source into the workpiece. The laser shock peening system also includes a transparent constraining layer disposed between the laser source and the absorptive layer. The transparent constraining layer is also configured to provide a pressure medium configured to direct multiple reflected laser generated shock waves from the workpiece back into the workpiece. The laser shock peening system also includes a transducer disposed on the workholding fixture and configured to detect multiple acoustic signals emitted from the workpiece. | 04-02-2009 |
Matthew Alan Gassaway, Portland, OR US
| Patent application number | Description | Published |
|---|---|---|
| 20110014061 | FAN ARRAY CONTROL SYSTEM - A fan array fan section in an air-handling system includes a plurality of fan units arranged in a fan array and positioned within an air-handling compartment One preferred embodiment may include an array controller programmed to operate the plurality of fan units at peak efficiency by computing the power consumed in various configurations and selecting the configuration requiring minimum power to operate. | 01-20-2011 |
Matthew Alan Jones, Christchurch NZ
| Patent application number | Description | Published |
|---|---|---|
| 20110021434 | Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof - The present invention provides a novel class of macrocyclic compounds, which are useful as cysteine protease inhibitors. Also provided are novel intermediates and methods of preparing the compounds. The invention also provides pharmaceutical compositions comprising the compounds. The compounds and compositions are useful in methods of treating or preventing one or more diseases associated with cysteine protease activity, particularly those associated with calpain activity. | 01-27-2011 |
Matthew Alan Minson, Spring, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20120130176 | Laryngoscope - The present invention is a self-retaining laryngoscope composed of a palate brace or blade, a slider, and a tongue blade. The angulated tongue blade puts less force on the blade, reduces trauma, and is not conducive for mechanical failure. The slider interacts with the tongue blade by widening the opening of the mouth, and acts as a bite block. The fenestrated palate blade provides an unobstructed view of the vocal cords during intubation, and allows removal of the laryngoscope over the endotracheal tube without displacing it. The result is a laryngoscope that requires only one hand to use properly, and has superior retraction due to its shape. | 05-24-2012 |
Matthew Alan Williams, San Mateo, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20080249079 | Pyrimidine Derivatives As Kinase Modulators and Method of Use - The invention provides compounds and methods for inhibition of kinases, more specifically IGF 1 R kinases. The invention also provides compounds and methods for inhibition of wildtype Abl. The invention provides compounds for modulating protein kinase enzymatic activity for modulating cellular activities such as proliferation, differentiation, programmed cell death, migration and chemoinvasion. Compounds of the invention inhibit, regulate and/or modulate kinase receptor signal transduction pathways related to the changes in cellular activities as mentioned above, and the invention includes compositions which contain these compounds, and methods of using them to treat kinase-dependent diseases and conditions. A compound of formula (I), or a pharmaceutically acceptable salt, hydrate, or prodrug thereof, wherein, V is NR | 10-09-2008 |